🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Connecticut › New Haven

Etid klinik pou Dyabèt Tip 2 nan New Haven, CT

10 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote New Haven (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • CMR of Greater New Haven, LLC, Hamden · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • CMR of Greater New Haven, LLC, Hamden · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • Yale University, New Haven
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Ap rekriteFaz 3
  • Yale School of Medicine, New Haven
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Ap rekriteFaz 3
  • Yale Diabetes Research, New Haven
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Ap rekrite
  • Yale, New Haven
Laj 14 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07579702

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

Ap rekriteVolontè an sante akeyi
  • Yale University, New Haven
Laj 40 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT07376655

Ultrasound Effects on Glycemic Control in T2DM

Ap rekrite
  • Yale-New Haven Hospital, New Haven
Laj 21 a 75 · Tout sèks · Mizajou Jan 27, 2026 · NCT05354947

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

Ap rekrite
  • Fair Haven Community Health Care (FHCHC), New Haven
Laj 18 ak plis · Tout sèks · Mizajou Dec 3, 2025 · NCT06658067

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

Ap rekriteVolontè an sante akeyi
  • Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven
Laj 18 a 60 · Tout sèks · Mizajou Jan 14, 2025 · NCT05776563

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan New Haven

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.